A detailed history of Lantern Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Lantern Wealth Advisors, LLC holds 7,400 shares of NVS stock, worth $790,172. This represents 0.5% of its overall portfolio holdings.

Number of Shares
7,400
Previous 7,500 1.33%
Holding current value
$790,172
Previous $757 Million 5.48%
% of portfolio
0.5%
Previous 0.59%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $9,527 - $10,847
-100 Reduced 1.33%
7,400 $716 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $692,025 - $761,550
7,500 New
7,500 $757 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lantern Wealth Advisors, LLC Portfolio

Follow Lantern Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantern Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantern Wealth Advisors, LLC with notifications on news.